Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats

Fuuun Kawano, Jun Tanihata, Shogo Sato, Sachiko Nomura, Akira Shiraishi, Kaoru Tachiyashiki, Kazuhiko Imaizumi

    Research output: Contribution to journalArticle

    17 Citations (Scopus)

    Abstract

    Glucocorticoids are known to increase the density and mRNA levels of β-adrenoceptors (β-AR) via the glucocorticoid receptor (GR) in many tissues. However, the effects of these changes in the skeletal and cardiac muscles remain relatively unknown. We have investigated the effects of dexamethasone on the expression of the β1-, β2-, and β3-AR mRNAs and GR mRNA in fast-twitch fiber-rich extensor digitorum longus (EDL), slow-twitch fiber-rich soleus (SOL), and left ventricle (LV) muscles by real-time quantitative RT-PCR. Male rats were divided into a dexamethasone group and control group. The weight, RNA concentration, and total RNA content of EDL muscle were 0.76-, 0.85-, and 0.65-fold lower, respectively, in the dexamethasone group than in the control group. The weight, RNA concentration, and total RNA content of SOL muscle were 0.92-, 0.87-, and 0.81-fold lower, respectively, in the dexamethasone group than in the control group; these differences were significant. However, the weight/body weight and total RNA content/body weight of LV muscle were 1.38- and 1.39-fold higher, respectively, in the dexamethasone group than in the control group, respectively; these differences were also significant. Dexamethasone significantly decreased GR mRNA expression in EDL muscle without changing the expression of the β1-, β2-, and β3-AR mRNAs. However, dexamethasone significantly decreased the expressions of β2-AR and GR mRNAs in SOL muscle and significantly increased β1-AR mRNA expression in LV muscle-without changing GR mRNA expression. These results suggest that the effects of dexamethasone on the expression of β1- and β2-AR mRNAs and muscle mass depend on the muscle contractile and/or constructive types.

    Original languageEnglish
    Pages (from-to)383-390
    Number of pages8
    JournalJournal of Physiological Sciences
    Volume59
    Issue number5
    DOIs
    Publication statusPublished - 2009 Sep

    Fingerprint

    Skeletal Muscle Ventricle
    Adrenergic Receptors
    Dexamethasone
    Heart Ventricles
    Messenger RNA
    Glucocorticoid Receptors
    Muscles
    RNA
    Control Groups
    Skeletal Muscle
    Weights and Measures
    Body Weight
    Glucocorticoids
    Real-Time Polymerase Chain Reaction
    Myocardium

    Keywords

    • β-Adrenoceptor mRNA
    • Glucocorticoid receptor mRNA
    • Muscle mass
    • Skeletal and left ventricle muscles
    • Synthesized glucocorticoid dexamethasone

    ASJC Scopus subject areas

    • Physiology

    Cite this

    Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats. / Kawano, Fuuun; Tanihata, Jun; Sato, Shogo; Nomura, Sachiko; Shiraishi, Akira; Tachiyashiki, Kaoru; Imaizumi, Kazuhiko.

    In: Journal of Physiological Sciences, Vol. 59, No. 5, 09.2009, p. 383-390.

    Research output: Contribution to journalArticle

    Kawano, Fuuun ; Tanihata, Jun ; Sato, Shogo ; Nomura, Sachiko ; Shiraishi, Akira ; Tachiyashiki, Kaoru ; Imaizumi, Kazuhiko. / Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats. In: Journal of Physiological Sciences. 2009 ; Vol. 59, No. 5. pp. 383-390.
    @article{71f58a866b99441db007e94b78ae4c20,
    title = "Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats",
    abstract = "Glucocorticoids are known to increase the density and mRNA levels of β-adrenoceptors (β-AR) via the glucocorticoid receptor (GR) in many tissues. However, the effects of these changes in the skeletal and cardiac muscles remain relatively unknown. We have investigated the effects of dexamethasone on the expression of the β1-, β2-, and β3-AR mRNAs and GR mRNA in fast-twitch fiber-rich extensor digitorum longus (EDL), slow-twitch fiber-rich soleus (SOL), and left ventricle (LV) muscles by real-time quantitative RT-PCR. Male rats were divided into a dexamethasone group and control group. The weight, RNA concentration, and total RNA content of EDL muscle were 0.76-, 0.85-, and 0.65-fold lower, respectively, in the dexamethasone group than in the control group. The weight, RNA concentration, and total RNA content of SOL muscle were 0.92-, 0.87-, and 0.81-fold lower, respectively, in the dexamethasone group than in the control group; these differences were significant. However, the weight/body weight and total RNA content/body weight of LV muscle were 1.38- and 1.39-fold higher, respectively, in the dexamethasone group than in the control group, respectively; these differences were also significant. Dexamethasone significantly decreased GR mRNA expression in EDL muscle without changing the expression of the β1-, β2-, and β3-AR mRNAs. However, dexamethasone significantly decreased the expressions of β2-AR and GR mRNAs in SOL muscle and significantly increased β1-AR mRNA expression in LV muscle-without changing GR mRNA expression. These results suggest that the effects of dexamethasone on the expression of β1- and β2-AR mRNAs and muscle mass depend on the muscle contractile and/or constructive types.",
    keywords = "β-Adrenoceptor mRNA, Glucocorticoid receptor mRNA, Muscle mass, Skeletal and left ventricle muscles, Synthesized glucocorticoid dexamethasone",
    author = "Fuuun Kawano and Jun Tanihata and Shogo Sato and Sachiko Nomura and Akira Shiraishi and Kaoru Tachiyashiki and Kazuhiko Imaizumi",
    year = "2009",
    month = "9",
    doi = "10.1007/s12576-009-0046-6",
    language = "English",
    volume = "59",
    pages = "383--390",
    journal = "Journal of Physiological Sciences",
    issn = "1880-6546",
    publisher = "Springer Japan",
    number = "5",

    }

    TY - JOUR

    T1 - Effects of dexamethasone on the expression of β1-, β2- and β3-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats

    AU - Kawano, Fuuun

    AU - Tanihata, Jun

    AU - Sato, Shogo

    AU - Nomura, Sachiko

    AU - Shiraishi, Akira

    AU - Tachiyashiki, Kaoru

    AU - Imaizumi, Kazuhiko

    PY - 2009/9

    Y1 - 2009/9

    N2 - Glucocorticoids are known to increase the density and mRNA levels of β-adrenoceptors (β-AR) via the glucocorticoid receptor (GR) in many tissues. However, the effects of these changes in the skeletal and cardiac muscles remain relatively unknown. We have investigated the effects of dexamethasone on the expression of the β1-, β2-, and β3-AR mRNAs and GR mRNA in fast-twitch fiber-rich extensor digitorum longus (EDL), slow-twitch fiber-rich soleus (SOL), and left ventricle (LV) muscles by real-time quantitative RT-PCR. Male rats were divided into a dexamethasone group and control group. The weight, RNA concentration, and total RNA content of EDL muscle were 0.76-, 0.85-, and 0.65-fold lower, respectively, in the dexamethasone group than in the control group. The weight, RNA concentration, and total RNA content of SOL muscle were 0.92-, 0.87-, and 0.81-fold lower, respectively, in the dexamethasone group than in the control group; these differences were significant. However, the weight/body weight and total RNA content/body weight of LV muscle were 1.38- and 1.39-fold higher, respectively, in the dexamethasone group than in the control group, respectively; these differences were also significant. Dexamethasone significantly decreased GR mRNA expression in EDL muscle without changing the expression of the β1-, β2-, and β3-AR mRNAs. However, dexamethasone significantly decreased the expressions of β2-AR and GR mRNAs in SOL muscle and significantly increased β1-AR mRNA expression in LV muscle-without changing GR mRNA expression. These results suggest that the effects of dexamethasone on the expression of β1- and β2-AR mRNAs and muscle mass depend on the muscle contractile and/or constructive types.

    AB - Glucocorticoids are known to increase the density and mRNA levels of β-adrenoceptors (β-AR) via the glucocorticoid receptor (GR) in many tissues. However, the effects of these changes in the skeletal and cardiac muscles remain relatively unknown. We have investigated the effects of dexamethasone on the expression of the β1-, β2-, and β3-AR mRNAs and GR mRNA in fast-twitch fiber-rich extensor digitorum longus (EDL), slow-twitch fiber-rich soleus (SOL), and left ventricle (LV) muscles by real-time quantitative RT-PCR. Male rats were divided into a dexamethasone group and control group. The weight, RNA concentration, and total RNA content of EDL muscle were 0.76-, 0.85-, and 0.65-fold lower, respectively, in the dexamethasone group than in the control group. The weight, RNA concentration, and total RNA content of SOL muscle were 0.92-, 0.87-, and 0.81-fold lower, respectively, in the dexamethasone group than in the control group; these differences were significant. However, the weight/body weight and total RNA content/body weight of LV muscle were 1.38- and 1.39-fold higher, respectively, in the dexamethasone group than in the control group, respectively; these differences were also significant. Dexamethasone significantly decreased GR mRNA expression in EDL muscle without changing the expression of the β1-, β2-, and β3-AR mRNAs. However, dexamethasone significantly decreased the expressions of β2-AR and GR mRNAs in SOL muscle and significantly increased β1-AR mRNA expression in LV muscle-without changing GR mRNA expression. These results suggest that the effects of dexamethasone on the expression of β1- and β2-AR mRNAs and muscle mass depend on the muscle contractile and/or constructive types.

    KW - β-Adrenoceptor mRNA

    KW - Glucocorticoid receptor mRNA

    KW - Muscle mass

    KW - Skeletal and left ventricle muscles

    KW - Synthesized glucocorticoid dexamethasone

    UR - http://www.scopus.com/inward/record.url?scp=69049083332&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=69049083332&partnerID=8YFLogxK

    U2 - 10.1007/s12576-009-0046-6

    DO - 10.1007/s12576-009-0046-6

    M3 - Article

    VL - 59

    SP - 383

    EP - 390

    JO - Journal of Physiological Sciences

    JF - Journal of Physiological Sciences

    SN - 1880-6546

    IS - 5

    ER -